Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Net Margin (2016 - 2025)

Historic Net Margin for Outlook Therapeutics (OTLK) over the last 7 years, with Q3 2025 value amounting to 14482.19%.

  • Outlook Therapeutics' Net Margin changed N/A to 14482.19% in Q3 2025 from the same period last year, while for Dec 2025 it was 7276.84%, marking a year-over-year decrease of 95187600.0%. This contributed to the annual value of 4416.22% for FY2025, which is 68035400.0% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Net Margin of 14482.19% as of Q3 2025.
  • Outlook Therapeutics' Net Margin's 5-year high stood at 14482.19% during Q3 2025, with a 5-year trough of 1338.75% in Q2 2025.